Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CareDx Raises FY2025 Sales Guidance from $367.000M-$373.000M to $372.000M-$376.000M vs $368.883M Est

Author: Benzinga Newsdesk | November 04, 2025 04:06pm
CareDx (NASDAQ:CDNA) raises FY2025 sales outlook from $367.000 million-$373.000 million to $372.000 million-$376.000 million vs $368.883 million estimate.

Posted In: CDNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist